Cost-effectiveness of follow-up invasive coronary angiography after percutaneous coronary stenting: a real-world observational cohort study in Japan
Conclusions
FUICA increased the costs but did not improve clinical benefits. Thus, FUICA is not economically more attractive than CF alone.
Trial registration number
UMIN000039768.
Source: BMJ Open - Category: General Medicine Authors: Shiina, T., Goto-Hirano, K., Takura, T., Daida, H. Tags: Open access, Health economics Source Type: research
More News: Angiography | Angioplasty | Cardiology | Coronary Angioplasty | Coronary Artery Bypass Graft | Economics | General Medicine | Heart | Heart Attack | Heart Failure | Japan Health | Percutaneous Coronary Intervention | Stroke | Study